Mindpeak builds automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Their tools assist cancer experts in providing reliable and reproducible diagnoses.

This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. Explainable AI (xAI) results provide the required trust of pathologists into their tools.

Mindpeak was founded in 2018 and is headquartered in Hamburg, Germany. The managing director is Felix Faber.

They develop AI-powered diagnostic software and integrate AI algorithms into histology-based in vitro diagnostics (IVDs), including companion diagnostics. Their AI is designed for clinical diagnostics, translational research, and clinical trial services, bridging the gap from diagnostics to precision medicine.

Mindpeak's various AI solutions include 0-click AI products that detect and quantify biomarkers and cancer tissue characteristics across a range of cancers and tissue types.